Gil Beyen

Chief Executive Officer and Executive Director

Mr Gil Beyen has been a CEO of private and listed biotech companies for more than 20 years. Before joining Montis, he served as CEO and Director of ERYTECH Pharma, a dual-listed, late clinical stage biopharma company, based in France and Boston, MA, for over 10 years. Prior to that, he was CEO and Managing Director of TiGenix, a cell therapy company he co-founded, and Director at Arthur D. Little, an international management consulting firm, in Brussels.

Mr Beyen holds a MSc in Bioengineering from the University of Leuven (Belgium) and an M.B.A. from the University of Chicago (USA).